Farnesyltransferase inhibitors: Novel compounds in development for the treatment of myeloid malignancies

Jorge E. Cortes, Razelle Kurzrock, Hagop M. Kantarjian

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint Dive into the research topics of 'Farnesyltransferase inhibitors: Novel compounds in development for the treatment of myeloid malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences